KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 121 filers reported holding KYMERA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,603,815 | -54.2% | 1,985,886 | -24.2% | 0.00% | -33.3% |
| Q2 2023 | $60,240,904 | -25.4% | 2,620,309 | -3.9% | 0.00% | -40.0% |
| Q1 2023 | $80,795,825 | -43.1% | 2,726,825 | -52.1% | 0.01% | +25.0% |
| Q4 2022 | $142,083,352 | +143.0% | 5,692,442 | +112.0% | 0.00% | 0.0% |
| Q3 2022 | $58,461,000 | -15.5% | 2,685,404 | -23.6% | 0.00% | 0.0% |
| Q2 2022 | $69,199,000 | -21.9% | 3,514,438 | +67.8% | 0.00% | 0.0% |
| Q1 2022 | $88,642,000 | -15.0% | 2,094,561 | +27.6% | 0.00% | -20.0% |
| Q4 2021 | $104,235,000 | +23.3% | 1,641,762 | +14.0% | 0.01% | +25.0% |
| Q3 2021 | $84,572,000 | +30.5% | 1,439,776 | +7.7% | 0.00% | +33.3% |
| Q2 2021 | $64,827,000 | +78.1% | 1,336,646 | +42.7% | 0.00% | +50.0% |
| Q1 2021 | $36,409,000 | +265.8% | 936,915 | +483.6% | 0.00% | +100.0% |
| Q4 2020 | $9,954,000 | – | 160,545 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |